genOway SA Share Price Xetra
Equities
JEH
FR0004053510
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
2023 | GenOway: sharp rise, broker initiates buy recommendation | CF |
2023 | GENOWAY : Euroland initiates buy coverage | CF |
Sales 2022 | 21.09M 22.57M 1.89B | Sales 2023 | 26.51M 28.37M 2.37B | Capitalization | 40.59M 43.44M 3.63B |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | 1M 1.07M 89.44M | EV / Sales 2022 | 1.87 x |
Net Debt 2022 | 4.16M 4.45M 372M | Net Debt 2023 | 2.97M 3.18M 266M | EV / Sales 2023 | 1.64 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-
| Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.58% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Founder | - | 01/99/01 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 01/99/01 | |
Raffy Kazandjian
BRD | Director/Board Member | - | - |
Patrick Blain
BRD | Director/Board Member | 72 | - |
1st Jan change | Capi. | |
---|---|---|
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- ALGEN Stock
- JEH Stock